Literature DB >> 8403377

Neurochemical alterations in Rett syndrome.

G L Wenk1, M O'Leary, C B Nemeroff, G Bissette, H Moser, S Naidu.   

Abstract

The Rett syndrome (RS) is a neurological disorder associated with severe mental deficiency and neurological manifestations of cortical and extrapyramidal dysfunction. The present report is (1) a postmortem brain study that compares the levels of choline acetyltransferase (ChAT) activity and the binding density of selected neurotransmitter receptors in four cases of RS and five normal controls of similar age and (2) a study of cerebrospinal fluid (CSF) concentrations of the endogenous tridecapeptide neurotensin in 12 RS patients and 8 controls of similar age. The level of ChAT activity was lower in many cortical and subcortical regions in the RS brains as compared to control levels. The number of NMDA, AMPA, mu opioid and neurotensin binding sites, as well as CSF concentrations of neurotensin, did not differ significantly from control levels. The results suggest that changes in specific neurotransmitter systems, particularly cholinergic neurons, in the thalamus, cerebellum and basal ganglia may underlie the progressive deterioration in motor and cognitive function characteristic of this disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403377     DOI: 10.1016/0165-3806(93)90084-n

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

Review 1.  Rett syndrome.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

2.  Cholinergic systems are essential for late-stage maturation and refinement of motor cortical circuits.

Authors:  Dhakshin S Ramanathan; James M Conner; Arjun A Anilkumar; Mark H Tuszynski
Journal:  J Neurophysiol       Date:  2014-12-10       Impact factor: 2.714

3.  A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Authors:  Craig A Erickson; David J Posey; Kimberly A Stigler; Jennifer Mullett; Adrian R Katschke; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

Review 4.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

5.  Ocular MECP2 protein expression in patients with and without Rett syndrome.

Authors:  Deepali Jain; Kamaljeet Singh; Sankar Chirumamilla; Genila M Bibat; Mary E Blue; Sakkubai R Naidu; Charles G Eberhart
Journal:  Pediatr Neurol       Date:  2010-07       Impact factor: 3.372

6.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.

Authors:  D F Wong; J C Harris; S Naidu; F Yokoi; S Marenco; R F Dannals; H T Ravert; M Yaster; A Evans; O Rousset; R N Bryan; A Gjedde; M J Kuhar; G R Breese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Adolescent Intermittent Ethanol (AIE) Enhances the Dopaminergic Response to Ethanol within the Mesolimbic Pathway during Adulthood: Alterations in Cholinergic/Dopaminergic Genes Expression in the Nucleus Accumbens Shell.

Authors:  Sheketha R Hauser; Patrick J Mulholland; William A Truitt; R Aaron Waeiss; Eric A Engleman; Richard L Bell; Zachary A Rodd
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

8.  Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.

Authors:  Michael G Aman; Robert L Findling; Antonio Y Hardan; Robert L Hendren; Raun D Melmed; Ola Kehinde-Nelson; Hai-An Hsu; Joel M Trugman; Robert H Palmer; Stephen M Graham; Allyson T Gage; James L Perhach; Ephraim Katz
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-03-15       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.